tert-Butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-enecarboxylate

Catalog No. :
ACMSXE605
CAS No. :
2007915-86-6
Molecular Formula :
C18H23NO4
Molecular Weight :
317.39

IUPAC Name:tert-butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-ene-1-carboxylate

tert-Butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-enecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$335.00Login to see priceInquiryInquiry
1g95%$839.00Login to see priceInquiryInquiry
5g95%$2507.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-enecarboxylate
IUPAC Nametert-butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-ene-1-carboxylate
MDL No.MFCD30472116
Molecular FormulaC18H23NO4
Molecular Weight317.39
SMILESCC(C)(C)OC(=O)C1CC(NC(=O)OCC2=CC=CC=C2)C=C1
InChI KeyVJQGPEDURCPBEI-UHFFFAOYSA-N
Synonymtert-butyl 4-(((benzyloxy)carbonyl)amino)cyclopent-2-enecarboxylate;2-Cyclopentene-1-carboxylic acid, 4-[[(phenylmethoxy)carbonyl]amino]-, 1,1-dimethylethyl ester
CAS No.2007915-86-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMSXE605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMSXE605 route product structure diagram
    ACMSXE6052007915-86-6
Inquiry

2. ACMSXE605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMSXE605 route product structure diagram
    ACMSXE6052007915-86-6
Inquiry

Comments (0)